• 検索結果がありません。

1. MUC gene expression and histogenesis of adenocarcinoma of the stomach. 2.Beta-catenin expression in intramucosal neoplastic lesions of the stomach : comparative analysis of adenoma/dysplasia, adenocarcinoma and signet ring cell carcinoma.

N/A
N/A
Protected

Academic year: 2021

シェア "1. MUC gene expression and histogenesis of adenocarcinoma of the stomach. 2.Beta-catenin expression in intramucosal neoplastic lesions of the stomach : comparative analysis of adenoma/dysplasia, adenocarcinoma and signet ring cell carcinoma."

Copied!
3
0
0

読み込み中.... (全文を見る)

全文

(1)1. MUC gene expression and histogenesis of adenocarcinoma of the stomach. 2.Beta-catenin expression in intramucosal neoplastic lesions of the stomach : comparative analysis of adenoma/dysplasia, adenocarcinoma and signet ring cell carcinoma. その他の言語のタイ トル. 著者 発行年 URL. 胃早期癌と腺腫/異形成のMUC遺伝子およびβ-カテ ニンの発現 1.胃分化型腺癌の組織発生とMUC遺伝子 発現 2.胃粘膜内腫瘍におけるβ-カテニン発現 : 腺腫/異形成、分化型腺癌と印環細胞癌の比較解析 イ ソウキガン ト センシュ イケイセイ ノ MUC イ デンシ オヨビ β カテニン ノ ハツゲン 1.イ ブンカガタ センガン ノ ソシキ ハッセイ ト MUC イデンシ ハツゲン 2. イ ネンマクナイ シュヨウ ニ オケル β カテニン ハツゲン : センシュ イ ケイセイ ブンカガタ センガン ト インカン サイ ボウガン ノ ヒカク カイセキ 塚下 しづき 2003-03-27 http://hdl.handle.net/10422/650.

(2) ñ. ò› “ ó Ÿ. ô. ³. !—˜›õö÷Ÿ. t Í  ø ¤. ùú›rtŸ. t Í û ü ý. ùúþØØØý. tÍ. tÍþ þÛ. tÍ. †º£¾‡. tÍ. 

(3) . !"#. $% &'('')*+ ', , .(/(01, 2 .&'(', ,.3/0'(.4/+ 4(.5/.32 1' , 2 .5/416789

(4) :;"< "#=>? (2 '+ (/2 .(/@ A.B+ (/@.3/(4'+ CD.@ EF GH IJ CK LLM KNOCIOOK .

(5) . . . . . . . . ë. . . . . . . . .       . . 

(6)            . !"# $%& #". '($)*+"# ,-.%/&0123456789:;<=%>?=8 @ AB$C 8DE+"# ,FG>?HIJKL&MN8&OPQ)RSMJTU %VW 78XYZ[)\]^*_&)RSM`a Jbc!%d_ TU OPQefZ[ Jgh1234568&ij 8BkJlm., n. o. pqrst uvBkwx0QyzC #{s |}d+.&HIJTU8!.,OP QM~VHI€‚JTU VW78XYZ[)\Jƒ„!%d_ TU ‚OPQM~ VHI8† ‡‚efZ[Jgh%OPQNˆ† †‚JTU 1234567Jlm.,OP QM~VHI ‰#"%Š ‹ ŒŽ     ‘’“0”   Ž    •   ‹     ‹   –— ˜%™š›œS=MNžVŸ% š›¡S=MNžVŸ%¢š›OPQ)RSMŸ £š )¤!.,¥¦§¨©ª«¬­J®#.¯°`aRtJ±#²³u´ bc!., VW7ƒ„µ&S¶©3©0C ·¸¹º»¹¼·¸¹½8S¶©3©0C ·¸¹¾¼¹¿† ¬ ­J®#%9À?ÁJ›2Ÿ*_›Âß-0 ÄÅ ÆÇ!%9ÈÉ*_ÊË&S%ÊË S%&SÌÍ&ÎÏS%SÌÍ&ÎÏS%Ð&ÎÏSÑVW )¤!., XYZ[)\ƒ„µÒ ½‡¬­J®#%À?Z[)\JÆÇ!., 1234567ƒ„µÓ ‹   ‹   ¬­J®#%Ô8Z[WÕ7 uvZ[P7£^. Ö!.,Ô7 ‰#"× *_× ØÑÄÅÆÇJ%Z[W7 ‰#"Ù   Ú*_Ù   Û£ÄÅÆÇJ%Z[P7 ‰#"97ÜÝÞßÆÇJ±à., È. É. VW7ƒ„µ™š€†á € â$ÊËSVWJã!., š0‡ ¾á ¾ â$&S¶©3©À?8äå% ÊËSJã!.æ¾‡á €â0Cà.,¢š0€¾á ºâ0&S¶©3©À?8äå%ÊËSJ ã!.æ†‡á ºâ0Cà.,¢š0çÊË&SJãè‚$ç_+%Ë­†¾á ºâ0Cà., XYZ[)\ƒ„µ™š0éá éâ0Ò ½‡À?Z[$Nˆêëì íî!. T!% š0 ‡¾á ¾â0%¢š0¾‡á ºâ0À?Z[$íî!., 1234567ƒ„µÔ7 ‰#"%ï7‚›× ¼ ؟%™š0¾ á €â% š0º á ½ 𠇽ð.

(7)  

(8)      .

(9) !"#$%&'()

(10) "#*+,-.&/012 3  4     

(11) 12 3     

(12) . !"#$%&'()

(13) "#5+,-. .&/% % %  . !"#$%% "#5+,. %6789:(

(14) -.&/+,;*<=>?@AB+,CDEFG<HI%JKLMN< L

(15) OP+, 4 QR;*% SR;*% 9:(

(16) "#*TUV+,12 3 QR;*% W9:(

(17) 8SR;*9:(L X

(18) "#5+,-.&/QR;*% SR;*%W +,6789:(

(19) YZ. [\. ;*+,<]%^-_`a89:(

(20) b%cd8efSR;*Cg hij"#kl%mno-pqh/rstuh

(21) SR;*Cgh/&Gv<8gwx(G yz]{|%}~-QR€?€80<Lscdij"#klf-‚ƒ„ - †hefQR;*CgF)%)9:(

(22) tuh

(23) SR;*C+,FG‡k8 ˆ‚QR;*C+,h‰tu<Ls ŠR‡$<LG<Z‹ŒdX:ŽFG  G<Z‹G ‘S$’Q$=>?@AB%+,<“”%}~-•–8 G<—˜(/&G8™š%›œ “”i%L&)=>?@AB%O’"#*%+,"#5+,6789 :(<%^-_`a9:(LX

(24) =>?@AB+,8ž'h)Q$%Ÿ +%¡ ~C¢£FG<p:L&v<8gwx(G ŠR‡$<. !"#$<%^ G& ŠR‡. $%m)QR<SR%^-=>?@AB%+,¤¥€B<¦~-a89:(

(25) YM. §\. ¨ © Q$%cd ª3«¬ 2  2 ­ ª3«®  ¯° ª2  -±˜'ª3²3-+FG ¨ © Q$%Ÿ +-³h/=>?@AB+,¡~C¢£hL& ¨ © =>?@AB+,%´µX:Q ŠR‡$<. !"#$ ŠR‡$%m)QR<S. R¶­ ® · 3¸ ª · ­ 2¹· ¶º»8¼LG.          ‘S$+ª3«¬ 2  2 ­ ª3«®  ¯° ª2  %´½8¾¿h/&G8Q$+ÀÁ¾¿ h/&L& ÂÃÄżR~Q‡k<Æ5ÇQ ŠR‡$-.&/ÈÉÊËÌÍ-ÎÏÐÑ ÒÓ+,C›œhżR~Q‡k8SR;*C+,h  8efSR;*C+,FG%-Ô h ŠR‡$ W8QR;*CÕÖhK× WefQR;*C+,FGv<Cgh

(26) ƒ

(27) Ø­ فCÚ&

(28) ij"#ÛÜX:ij"#żR~‡kklmno-pq FG%-Ôh ŠR‡$klf-‚ƒ„- †FGv<Cgh

(29) FL˜×QÅ ¼R~‡k< ŠR‡$¼LGÝC_hQ$%cd ª3«¬ 2  2 ­ ª3«®  ¯° ª2  -±˜ 'ª3²3-+FGv<CÞ:X-h

(30) yz=?@AB%"#ÇqßC›œh±à%‘S$áQ$=?@AB%+,âã8“”% }~<¡~-•–FG<%äÛ-Ôh/Q$%Ÿ +-r&/=?@AB+,âã8ž' h)¡~C¢£hL&<&Kå

(31) LæäCgh

(32) v%JK-ÂÃÄQ$+-çèLæäCé‹

(33) )% sêëìÌ%Ìí-îFG. ï ï.

(34)

参照

関連したドキュメント

To examine the expression of cell competition markers at the interface between normal and transformed epithelial cells, we focused on studying the p53 signature of the human

Character- ization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. IGFBP-4 is an inhibitor of canonical Wnt signalling

In humans, three types of TFF (TFF1–3) and their characteristic and co- ordinated distribution together with MUC mucin have been reported. That is, a combination of TFF1 with MUC5AC

Standard domino tableaux have already been considered by many authors [33], [6], [34], [8], [1], but, to the best of our knowledge, the expression of the

For staggered entry, the Cox frailty model, and in Markov renewal process/semi-Markov models (see e.g. Andersen et al., 1993, Chapters IX and X, for references on this work),

Keywords: Convex order ; Fréchet distribution ; Median ; Mittag-Leffler distribution ; Mittag- Leffler function ; Stable distribution ; Stochastic order.. AMS MSC 2010: Primary 60E05

In particular, we consider a reverse Lee decomposition for the deformation gra- dient and we choose an appropriate state space in which one of the variables, characterizing the

modular proof of soundness using U-simulations.. &amp; RIMS, Kyoto U.). Equivalence